If You Invested in Cue Health Inc. (HLTH)
Looking for the current price? See the HLTH quote & overviewWhat $1,000 or $10,000 in HLTH Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Jul 20, 2015 |
|---|---|---|---|---|
| $1,000 | — | $0 -100% | $0 -100% | $0 -100% |
| $10,000 | — | $0 -100% | $0 -100% | $0 -100% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for HLTH$1,000 Investment Over Time
HLTH vs S&P 500Year-by-Year Returns
HLTH annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2015 | $6.97 | $2.82 | -59.5% | -59.5% |
| 2016 | $2.77 | $2.10 | -24.2% | -69.9% |
| 2017 | $2.40 | $1.35 | -43.7% | -80.6% |
| 2018 | $1.35 | $0.42 | -68.9% | -94.0% |
| 2019 | $0.44 | $0.12 | -71.9% | -98.2% |
| 2021 | $20.00 | $13.41 | -33.0% | +92.4% |
| 2022 | $14.67 | $2.07 | -85.9% | -70.3% |
| 2023 | $2.13 | $0.16 | -92.4% | -97.7% |
| 2024 | $0.23 | $0.00 | -100.0% | -100.0% |
About Cue Health Inc.
Laboratory Analytical Instruments · NASDAQ
Cue Health Inc. was a healthcare technology company that developed diagnostic-enabled care products for at-home and point-of-care testing and later filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code to pursue a wind down of its business. The company, associated with the Nasdaq ticker HLTH in its public releases, was founded in 2010 and headquartered in San Diego, California.
Cue's platform was designed to give individuals and healthcare providers access to lab-quality diagnostic tests outside traditional laboratory settings, including at home and in point-of-care environments. The company also described its offering as including on-demand telehealth consultations and treatment options for health and wellness needs. Its customer categories included federal and state public sector agencies, healthcare providers, enterprises, and individual consumers.
The company's diagnostic portfolio included its COVID-19 test, which received De Novo authorization from the U.S. Food and Drug Administration, and its molecular Mpox test, which received Emergency Use Authorization for point-of-care use. Cue reported ownership of more than 100 patents and positioned its technology around molecular diagnostics, connected testing, and diagnostic-enabled care.
In 2024, Cue announced that it had filed for Chapter 7 bankruptcy protection in the District of Delaware after efforts to reduce costs, improve operating efficiency, obtain additional financing, or complete a strategic transaction. The proceeding was intended to wind down the business, gather and sell company assets, and use proceeds to pay creditors in accordance with the Bankruptcy Code.
Frequently Asked Questions
Cue Health Inc. investment returns
How much would $1,000 invested in Cue Health Inc. be worth today?
If you invested $1,000 in Cue Health Inc. (HLTH) 10 years ago on 2016-07-18, your investment would be worth $0 today, representing a -100.0% total return, growing at a compounded rate of -71.4% per year (CAGR).
Has Cue Health Inc. outperformed the S&P 500?
Over the past 10 years, HLTH returned -100.0% compared to +246.9% for the S&P 500, underperforming the benchmark by 346.9 percentage points.
What is Cue Health Inc.'s average annual return?
The compound annual growth rate (CAGR) of HLTH over the past 10 years is -71.4%, growing at a compounded rate each year. Individual years vary significantly — HLTH's best recent year was 2016 (-24.2%) and worst was 2024 (-100.0%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
